reviewTop 1% cited
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial
Pharmacology Biochemistry and Behavior · 2003 · Vol. 75(3) · pp. 651–659
Nicolette S L Perry(University of Otago)Chloë S C Bollen(North Tyneside General Hospital)Elaine K. Perry✉(North Tyneside General Hospital)Clive Ballard(North Tyneside General Hospital)
Medicinal Plants and NeuroprotectionCholinesterase and Neurodegenerative DiseasesEssential Oils and Antimicrobial ActivityTolerabilityMedicineAcetylcholinesteraseAchéPharmacologyDementiaBlood pressureClinical trialInternal medicineDisease
MeSH terms
Administration, OralAgedAged, 80 and overAlzheimer DiseaseAnimalsCholinesterase InhibitorsCholinesterasesFemaleHumansMalePhytotherapyPilot ProjectsPlants, MedicinalSalvia
Citations
384
FWCI
24.36
field-weighted impact
References
59
Percentile
100%
vs. same field & year
Citations per year
Cited by
The in vitro screening for acetylcholinesterase inhibition and antioxidant activity of medicinal plants from Portugal
Journal of Ethnopharmacology · 2006 · 481 citations
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
Frontiers in Pharmacology · 2018 · 366 citations
Biological effects of essential oils – A review
Food and Chemical Toxicology · 2007 · 7,577 citations
References
A new and rapid colorimetric determination of acetylcholinesterase activity
Biochemical Pharmacology · 1961 · 26,665 citations
Synergistic and antagonistic interactions of anticholinesterase terpenoids in Salvia lavandulaefolia essential oil
Pharmacology Biochemistry and Behavior · 2003 · 352 citations
Polyphenolics of Salvia—a review
Phytochemistry · 2002 · 709 citations
Clinical diagnosis of Alzheimer's disease
Neurology · 1984 · 27,910 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.